Filing metadata

Accession number
0001104659-22-000973
Form type
Form 4
Filer
Nabriva Therapeutics plc
CIK
CIK 1641640
Filed
Jan 04, 2022
Reporting period
Dec 31, 2021
Description
Insider transaction

Explore SEC Filings Hub